HSG & Lipiodol : Current Potential in Infertility and Endometriosis

Speaker: Dr. Neil Johnson
This Grand Rounds Dr Neil Johnson explores the use of HSG with Lipiodol which has shown fertility benefit particularly in endometriosis patients. Minimally-invasive and well tolerated by women you can view some of his past research in PubMed here.
The outcomes of a recent multi-centre randomized controlled trial was also published and presented last year at the WCE2017 (World Congress on Endometriosis): http://bit.ly/2PnZT2Q.
Dr. Neil Johnson is the Medical Director of Fertility Plus and Gynaecologist with ADHB. He is also a Fertility Specialist with Repromed. He trained in both the UK and New Zealand, and has completed the advanced training program necessary to accredit as a Subspecialist in Reproductive Endocrinology & Infertility. He is now involved with training and examining other fertility subspecialists throughout Australia and New Zealand.
With a national and international reputation as a leader in gynaecology and fertility clinical research, Neil is leading the Australasian multicentre fertility research network REACT-ANZ. His main areas of research interest currently include evidence based fertility treatments, endometriosis, polycystic ovaries and ovarian reserve. He has developed an innovative treatment for unexplained and endometriosis-related infertility, using Lipiodol (a poppy seed oil).

This webinar is generously supported by an educational grant from Guerbet LLC.